Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial

Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's Revision value changed from v3.5.3 to v3.5.4, reflecting a small maintenance/update to the page's backend or documentation. No substantive content or functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-05-14T23:12:33.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new page revision v3.5.3 was published, replacing the previous v3.5.2. This is a metadata/version update and does not alter the study details displayed on the page.
    Difference
    0.1%
    Check dated 2026-04-30T15:44:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2; the previous tag was v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:44:29.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T15:40:55.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:08:39.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The old 3.4.1 notice and the government funding lapse notice have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:23:00.000Z thumbnail image

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.